The present invention is related to pharmaceutical product for injection comprising a container including a closure suitable for preparations for injection the container containing an acid labile proton pump inhibitor a salt thereof a solvate of the acid labile proton pump inhibitor or a salt thereof wherein the container and closure are made of material which essentially does not release zinc ions.

The invention relates to a method for the preparation of lyophilized pantoprazole by freeze drying of aqueous solution of pantoprazole ethylenediamine tetraacetic acid and/or a suitable salt thereofand sodium hydroxyde and/or sodium carbonate. The preparations produced have advantageous properties and are suitable for injection solutions. The pantoprazole injection for parenteral administrationis produced by the dissolution of the pantoprazole in a suitable solvent - physiological solution. The ...

The invention relates to (-)-pantoprazole magnesium and its hydrates and to medicaments comprising these compounds.

Dosage forms for oral administration of the magnesium salt of (S)-pantoprazole are described.

Dosage forms for oral administration of the magnesium salt of pantoprazole are described.

The invention relates to a novel process for preparing (S)-pantoprazole using a chiral zirconium complex or a chiral hafnium complex.

Dosage forms for oral administration of the magnesium salt of (S)-pantoprazole are described.(From US2011171303 A1)

Dosage forms for oral administration of the magnesium salt of pantoprazole are described.